Defining Treatment Aims for Methylation, MTHFR and Pyroluria

FXMedicine's picture

Defining Treatment Aims for Methylation, MTHFR & Pyroluria

So you've tested a patient for MTHFR SNPs and for Mauve Factor/Kryptopyrroles. What now?

Methylation and Pyrroles are hot topics in integrative medicine, yet controversy surrounds both their clinical significance and the best way to treat patients who have demonstrated aberrant biochemical results.

In today's podcast, Belinda Reynolds takes us through the complexities, the realities and the traps which practitioners sometimes find themselves in when oversimplifying these seemingly simple biochemical "wheels"


Belinda Reynolds is a dietitian and Education Manager at BioCeuticals. She graduated with an Honours Degree in Nutrition and Dietetics, and has been involved in the complementary medicine industry for over 15 years. Her key interests are immune modulation, the human microbiome and the impact they have on overall health.

OTHER PODCASTS WITH BELINDA INCLUDE:


A new podscast episode on the topic of Pyrrole Disorder is coming soon, If you havent already, subscribe to our eNews to be notified


DISCLAIMER: 

The information provided on FX Medicine is for educational and informational purposes only. The information provided on this site is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you have read here raises questions or concerns regarding your health. 

Share this post: 

SIGN UP TO OUR FREE eNEWS

FXMedicine's picture
FX Medicine Podcast
FX Medicine is at the forefront of ensuring functional and integrative medicine gains the recognition it deserves and ultimately establishes itself as an integral part of standard medical practice. Hosted by Andrew Whitfield-Cook, our podcasts are designed to promote research and evidence-based therapeutic practises, acting as a progressive force for change and improvement in patient health and wellbeing.